Abeona Therapeutics (ABEO) Invested Capital (2010 - 2026)

Abeona Therapeutics' Invested Capital history runs 17 years deep, the most recent figure standing at $158.3 million for Q1 2026.

• In Q1 2026, Invested Capital rose 219.46% year-over-year to $158.3 million; the TTM figure through Mar 2026 stood at $158.3 million (up 219.46% YoY), while the FY2025 annual figure was $171.4 million, up 243.17% from the prior year.
• Invested Capital was $158.3 million for Q1 2026 at Abeona Therapeutics, down from $171.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $180.1 million in Q3 2025 to a low of -$8.9 million in Q1 2024.
• Historically, Invested Capital has averaged $61.7 million across 5 years, with a median of $26.8 million in 2022.
• Biggest YoY gain for Invested Capital was 707.52% in 2024; the steepest drop was 147.39% in 2024.
• A 5-year view of Invested Capital shows it stood at $26.8 million in 2022, then tumbled by 44.6% to $14.8 million in 2023, then jumped by 236.96% to $50.0 million in 2024, then surged by 243.17% to $171.4 million in 2025, then decreased by 7.68% to $158.3 million in 2026.
• The last three Invested Capital figures came in at $158.3 million (Q1 2026), $171.4 million (Q4 2025), and $180.1 million (Q3 2025), per Business Quant data.